
Loading, please wait...

Loading, please wait...

The landmark Prevention of Urinary Stones with Hydration (PUSH) trial in The Lancet challenges a long-held medical dogma. It shows that drinking more water may not prevent kidney stone recurrence. For generations, practitioners have advised patients to increase fluid intake. However, this robust study suggests that hydration alone cannot solve the problem. Therefore, we must review the trial's methodology and explain why comprehensive metabolic evaluations remain crucial.
Researchers conducted a large-scale, randomized controlled trial across six major academic centers. They enrolled 1,658 participants aged 12 years and older who had a history of urinary stones and low urine output. One group received standard medical advice, while the other group underwent an intensive behavioral program. This program utilized smart water bottles, coaching, reminders, and personalized hydration targets. Subsequently, the researchers followed up with the participants over two years to track stone recurrence rates.
The intervention successfully increased fluid consumption, which led to higher urine output. Nevertheless, this change did not translate into a reduction in clinical events. After two years, symptomatic stone recurrence occurred in 19% of the intervention group and 20% of the standard-care group. Consequently, there was no statistically significant difference between the two cohorts. Furthermore, increased hydration did not stop new stone formation, stone growth, or painful episodes. Indeed, participants reported more frequent urination and nocturia, though no serious safety issues occurred.
Dr. Manoj Kumar Singhal, a leading nephrologist, notes that kidney stone recurrence is fundamentally a metabolic disorder. Low water intake is rarely the sole cause of the disease. Consequently, many patients continue to develop stones despite drinking enough water. These individuals often have underlying risk factors like excess dietary salt, high animal protein intake, and abnormal calcium or uric acid levels. Therefore, a simple recommendation to drink more water is insufficient. Instead, clinicians should perform a comprehensive metabolic evaluation, including a 24-hour urine analysis. This approach allows doctors to design personalized prevention strategies for long-term patient health.
Q1: Why did increased hydration fail to reduce stone recurrence in the PUSH trial?
Although participants drank more fluids, the modest increase in urine output was not enough to overcome underlying metabolic abnormalities. Kidney stones form due to complex chemical imbalances in the urine, which water alone cannot correct.
Q2: What other risk factors contribute to recurrent kidney stones?
Many patients have underlying issues such as high sodium consumption, excess animal protein intake, and obesity. Additionally, abnormal levels of calcium, oxalate, or uric acid in the urine drive stone formation.
Q3: How should clinicians evaluate patients with recurrent kidney stones?
Doctors should order a 24-hour urine analysis rather than relying solely on hydration advice. This diagnostic tool helps identify specific metabolic errors and allows for personalized dietary or medical interventions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Lancet PUSH study shows that behavioral hydration interventions do not reduce kidney stone recurrence, highlighting the role of metabolic factors....
2 months ago

A comprehensive 50-year study reveals an 82% decrease in overall US stroke mortality from 1970 to 2023. While ischemic and hemorrhagic stroke deaths dropped significantly due to clinical and public health advances, racial disparities persist, with Black adults continuing to experience the highest mortality rates.
Today

A multicenter study identifies a three-metabolite gut microbiota panel (3-hydroxydecanoic acid, γ-Glu-Leu, and propionic acid) for early risk stratification of gestational diabetes mellitus in the first trimester, offering superior predictive accuracy over standard clinical risk factors before 24 weeks.
Today

A breakthrough study reveals how METTL14-mediated m6A methylation of KRT17 drives pulmonary arterial smooth muscle cell proliferation via LCN2, offering new therapeutic targets for pulmonary vascular remodeling.
Today

A cadaveric study demonstrates that the Chinese knotting technique significantly improves maximum load capacity and reduces graft relaxation length in posterior cruciate ligament reconstruction, offering superior biomechanical stability compared to conventional reconstruction methods without altering stiffness.
Today

Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Today